Gabapentin

DB00996ApprovedInvestigationalSmall moleculeAnti-epileptic AgentMiscellaneous Anticonvulsants

Gabapentin is an anticonvulsant medication used in the management of peripheral neuropathic pains, postherpetic neuralgia, and partial-onset seizures. Gabapentin is a structural analogue of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) that was first approved for use in the United States in 1993.

Chemical structure of Gabapentin
Mechanism
Curator reviewed · 12 references
Primary indication
In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures, with or without secondary generalization, in patients 3 years of age...Curator reviewed · 7 structured indications
Formula / weight
C9H17NO2 · 171.2368 g/mol (avg)
First approval
Canada, 1998 · United States, 1993
Code names
CI-945 · DM-1796 · GOE-3450
Brand names
  • Gabarone
  • Gralise
  • Neurontin
  • Relgaabi

Resolves to

Structure
InChIKeyUGJMXCAKCUNAIE-UHFFFAOYSA-NSMILESNCC1(CC(O)=O)CCCCC1
Transporters

What you can answer from here — as of September 20, 2026

8Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
1,258Drug interactionsStructured to mechanism, not free text
Sign in
402Clinical trialsPhase, status and sponsor resolved per trial
Sign in
7Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
2,927Marketed productsAcross 11 countries and 327 labellers
Sign in
1ATC codeIncluding every combination product, plus 29 drug categories
Sign in
41+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Gabapentin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account